Abstract
129P Association of clinico-pathological markers with longitudinal liquid biopsy (LB) results predicts outcome in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have